Cited by 55Pancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesNeuroendocrine Tumor Research Advances

Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?

Sharib, Jeremy M., Fonseca, Annabelle L., Swords, Douglas S., Jaradeh, Katrin, Bracci, Paige M., Firpo, Matthew A., Hatcher, Stacy, Scaife, Courtney L. +6 more·2018·Surgery

Abstract

Background Significant overtreatment of intraductal papillary mucinous neoplasms can be attributed to low specificity of the current International Consensus Guidelines as well as nonconformity with the guidelines. We compare the ability of the 2012 and revised 2017 intraductal papillary mucinous neoplasms International Consensus Guidelines to predict high-grade dysplasia/invasive cancer and to determine the preoperative variables that predict resection of benign or low-grade dysplasia in tertiary care centers. Methods Clinical, radiographic, and pathologic data for resected intraductal papillary mucinous neoplasms at 3 high-volume National Cancer Institute Cancer Centers were reviewed and the 2012 and 2017 consensus criteria were retrospectively applied. When International Consensus Guidelines were not met, clinical decision analysis was used to determine the primary indication for resection. Logistic regression identified variables associated with pathologic grade. Results Records for a total of 251 patients were reviewed, 129 of whom (52%) had low-grade dysplasia. The revised 2017 International Consensus Guidelines had high sensitivity (98.4%) and negative predicted value (96.1%), and all high-risk stigmata predicted high-grade dysplasia/invasive cancer; however, specificity remained low (14.8%). Nonconformity with International Consensus Guidelines was the most powerful predictor of low-grade dysplasia on final pathologic examination (9.5; 2.12-40.78). Independent predictors of low-grade dysplasia included age younger than 50 (2.46; 1.08-5.62), fine-needle aspiration without epithelial cells (2.6; 1.43-4.72), and normal duct diameter (3.07; 1.99-4.75). Diabetes developed in 30% of patients after resection. Conclusion Management of intraductal papillary mucinous neoplasms remains clinically challenging. Low specificity of the International Consensus Guidelines and nonconformity with the guidelines continue to contribute to unnecessary pancreatic resections. Improved tools for disease classification as well as a better understanding of the natural history, biology, and rates of progression of intraductal papillary mucinous neoplasms are needed to avoid surgical overtreatment of low-grade intraductal papillary mucinous neoplasms.

Integrity signals

Registry

Crossref · 10.1016/j.surg.2018.07.014

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sharib, J. M., Fonseca, A. L., Swords, D. S., Jaradeh, K., Bracci, P. M., Firpo, M. A., Hatcher, S., Scaife, C. L., Wang, H., Kim, G. E., Mulvihill, S. J., Maitra, A., Koay, E. J., & Kirkwood, K. S.
Affiliations
  • University of California, San Francisco (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • University of Utah (US)
Corresponding author
Kirkwood, Kimberly S.
Venue
Surgery
Publisher
Elsevier BV
Published
2018-12
Volume
164
Issue
6
Pages
1178-1184
ISSN
0039-6060 (ISSN-L)
OpenAlex
W2888895287
Cited by
55
References
4
Citations by year
2026: 3 · 2025: 9 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 3
FWCI
1.97
Type
journal article
Language
en
Open access
closed
Locations
  • Surgery (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (U01CA151650, R03CA115225, R33CA155586, P30CA042014)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
Keywords
pancreatic ductal adenocarcinoma, surgical overtreatment, high-grade dysplasia, low-grade dysplasia, pancreatic resection, fine-needle aspiration, pancreatic duct diameter, clinical decision-making, guideline adherence
MeSH terms
Medical Overuse, Pancreatic Intraductal Neoplasms, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pancreas, Retrospective Studies, Practice Guidelines as Topic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review